A detailed history of Hemington Wealth Management transactions in Exact Sciences Corp stock. As of the latest transaction made, Hemington Wealth Management holds 34 shares of EXAS stock, worth $1,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34
Previous 38 10.53%
Holding current value
$1,820
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$49.33 - $71.97 $197 - $287
-4 Reduced 10.53%
34 $1,000
Q3 2024

Nov 12, 2024

BUY
$42.43 - $70.83 $1,612 - $2,691
38 New
38 $2,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.47B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.